Compass Pathways 新闻与活动
在场
Compass Pathways 是一家在股票代码 CMPS (GB) 下上市的公司。
高管
查看带有其 28 名主要高管的组织结构图
Compass Pathways 搜索最多的简介
高管在Compass Pathways变化
- Steve Levine 曾任 Senior Vice President, Patient Access and Medical Affairs, 现升职为 Chief Patient Officer (新闻发布的2025一月21号).
创建提醒
跟踪 Compass Pathways 的高管变动
生物技术
Compass Pathways 拥有 2,349 家竞争者，其中包括 Astellas Gene Therapies (美国(美洲))、Eurofins (卢森堡) 和 BitBiome (美国(美洲))。
Popular M&A news in 生物技术
- Paratek Pharmaceuticals 已收购 OptiNose (公布2025六月25号).
- Illumina has announced the acquisition of SomaLogic (公布2025六月23号).
- Actio Biosciences 刚刚宣布为 66 筹款数百万美元。 (公布2025六月19号).
生物技术 行业的其他推荐联系人
消息
Compass Pathways 的最新新闻稿
- Compass Pathways - News & events - News
- Compass Pathways - News & events - Events & presentations
- Mental Health Care News, Articles & Stories from Compass Pathways
- Study results of psilocybin treatment in bipolar II depression published in JAMA Psychiatry | Compass Pathways
- Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment-resistant depression, and launches new research center | Compass Pathways
- Mental Health Care News, Articles & Stories from Compass Pathways
- Mental Health Care News, Articles & Stories from Compass Pathways
- COMPASS Pathways announces publication of first study evaluating potential of AI model to predict outcomes of COMP360 psilocybin treatment in treatment-resistant depression | COMPASS Pathways
- COMP360 psilocybin treatment in TRD with antidepressants | COMPASS Pathways
- COMPASS Pathways announces publication of positive data from treatment-resistant depression phase 2 clinical trial of COMP360 psilocybin alongside antidepressants in Nature journal, Neuropsychopharmacology | COMPASS Pathways
- View more press releases Close
